Literature DB >> 5303009

[Serological relationship of group II adenoviruses].

R Wigand.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 5303009

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  9 in total

1.  INACTIVATION OF THE INFECTIVITY OF VIRAL HEMAGGLUTINATING ANTIGENS WITH THE USE OF BETAPRONE.

Authors:  J L SEVER; G A CASTELLANO; W PELON; R J HUEBNER; F WOLMAN
Journal:  J Lab Clin Med       Date:  1964-12

2.  NEUTRALIZATION OF THE ADENOVIRUSES TYPES 1 TO 28: SPECIFICITY AND ANTIGENIC RELATIONSHIPS.

Authors:  R WIGAND; H BAUER; F LANG; W ADAM
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  Observations on some little-known adenoviruses.

Authors:  L ROSEN; J F HOVIS; J A BELL
Journal:  Proc Soc Exp Biol Med       Date:  1962-10

4.  A hemagglutination-inhibition technique for typing adenoviruses.

Authors:  L ROSEN
Journal:  Am J Hyg       Date:  1960-01

5.  Further observation on typing adenoviruses and a description of two possible additional serotypes.

Authors:  L ROSEN; J F HOVIS; J A BELL
Journal:  Proc Soc Exp Biol Med       Date:  1962 Aug-Sep

6.  Epidemiology of group II adenoviruses.

Authors:  D Jung; R Wigand
Journal:  Am J Epidemiol       Date:  1967-03       Impact factor: 4.897

7.  Serological relationship between adenovirus haemagglutinins of group 2.

Authors:  R Wigand; J A Kasel; D W Alling; V Knight
Journal:  Nature       Date:  1965-09-11       Impact factor: 49.962

8.  [Serologically intermediary adenovirus strains].

Authors:  R Wigand
Journal:  Arch Gesamte Virusforsch       Date:  1965

9.  [Comparative studies on hemagglutinins of adenovurs strains of group I and II].

Authors:  W Bauer; R Wigand
Journal:  Arch Gesamte Virusforsch       Date:  1967
  9 in total
  13 in total

1.  Serologically atypical adenovirus strains of subgenus D are different in their genome from the respective prototypes.

Authors:  T Adrian; B Best; R Wigand
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

2.  [Successive multiple immunization with adenoviruses].

Authors:  R Wigand; J T Kho
Journal:  Z Med Mikrobiol Immunol       Date:  1970

3.  Neutralization of adenovirus toxins: specificity and antigenic relationships.

Authors:  N Döring; C X Nguyen; R Wigand
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

4.  Serologically intermediate adenovirus strains: a regular feature of group II adenoviruses.

Authors:  R Wigand; D Fliedner
Journal:  Arch Gesamte Virusforsch       Date:  1968

5.  [Adenovirus strains of subgroup II with unusual serological properties].

Authors:  R Wigand
Journal:  Z Med Mikrobiol Immunol       Date:  1970

6.  [Type-specific antigens of adenovirus].

Authors:  W Meiser; J Lange; D Loytved; R Wigand
Journal:  Arch Gesamte Virusforsch       Date:  1969

7.  Immunological relationship among human adenoviruses of subgenus D.

Authors:  R Wigand; D Keller; I Werling
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  New human adenovirus associated with respiratory illness: candidate adenovirus type 39.

Authors:  J C Hierholzer; M C Kemp; G W Gary; H C Spencer
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

9.  Immunological basis of the adenovirus 8-9 cross-reaction.

Authors:  J C Hierholzer; W R Dowdle
Journal:  J Virol       Date:  1970-12       Impact factor: 5.103

10.  Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers.

Authors:  J C Hierholzer; W C Gamble; W R Dowdle
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.